Seeed Studio reBot Arm B601-DM is a fully open-source 6-axis robotic arm (plus a parallel gripper) designed to lower the ...

For more information about this library please visit us at http://www.locoduino.org/spip.php?article228 in french or In extras folder, click on Doc/index.html to have ...

I’m already loving this device, and I haven’t even touched one. Arduino announced it has collaborated with M5Stack to develop the new compact and powerful Nesso N1 IoT development kit. This system ...

From story times in Dobson to tax help in Elkin to barista training in Mount Airy, the Northwestern Regional Library system is doing more than ever, director Joan Sherif told the Surry County Board of ...

In brief: A few months after acquiring Arduino, Qualcomm is introducing its first product designed to combine its processor technology with the "maker" ethos of the Italian company. Unsurprisingly, ...

Five months after acquiring Arduino, the open-source hardware and software company best known for its UNO and Nano microcontroller board for hobbyists, Qualcomm is looking to make another big splash ...

Qualcomm, which purchased microcontroller board manufacturer Arduino last year, just announced a new single-board computer that marries AI with robotics. Called the Arduino Ventuno Q, it uses Qualcomm ...

Thousands of people are expected to hit the road across Broward and Miami-Dade counties on Saturday as part of this year's Dolphins Cancer Challenge. The annual event, which is now in its 16th year, ...

The Miami Dolphins announced today that the Dolphins Cancer Challenge (DCC) has surpassed a historic $100 million raised, with 100 percent of funds supporting life-saving cancer research and care at ...

With one month until DCC XVI, the Dolphins Cancer Challenge (DCC) announced Grammy Award-winning rock band, Blues Traveler, as the headliner for the Finish Line Celebration at its signature ride, ...

Field-programmable gate array (FPGA) designer DCC Technology recently held a shareholders' meeting and approved a company name change. After completing administrative procedures, the company ...

DCC-3009 is a pan-inhibitor targeting primary and secondary KIT mutations in advanced GIST, aiming to overcome resistance to prior therapies. The phase 1/2 study focuses on determining the optimal ...